Experts stress that the verdict should not be seen as a case of weak IP rights. An Express Pharma report On April 1, In a 112-page judgment, the... ...
http://pharma.financialexpress.com/sections/management/2021-sc-verdict-on-glivec-an-ip-milestoneIncreasing evidence over the last decade has pointed to the patent system being a bottleneck for research itself and access to affordable medicines... ...
http://www.livemint.com/Page/Id/2.0.1589047945People living with HIV, cancer patient groups and public health activists came out on the streets on Wednesday demanding that India reject the... ...
http://www.thehindu.com/news/national/hiv-cancer-patients-seek-access-to-affordable-medicines/article4603574.eceThe government is likely to address concerns related to intellectual property rights (IPR) in several international forums through the year,... ...
http://www.smartinvestor.in/market/Econnews-169985-Econnewsdet-After_Glivec_verdict_India_might_face_patent_regime_heat.htmMany in the Indian pharmaceutical industry as well as civil society are worried over the demands raised by the European Union (EU), as India moves... ...
http://www.smartinvestor.in/market/Econnews-169518-Econnewsdet-Fear_in_Indian_pharma_over_EUs_demand_to_seize_drugs_in_transit.htm